Press RELEASE
Brussels, 3 February 2012
Release: Immediate
WORLD CANCER DAY 2012: EAHP AND ESOP ISSUE JOINT CALL FOR PHARMACIST DEVELOPMENT TO ADVANCE CANCER CARE
On the eve of
World Cancer Day
the European Association of Hospital Pharmacists (EAHP) and the
European Society of Oncology Pharmacy (ESOP) issued a joint call for
hospital pharmacist development in order to further advance cancer
patient care and outcomes.
Pharmacists
play a key part in cancer care in such roles as medical oncology,
haematology, palliative care and chemotherapy preparation services.
Appropriately trained and competent pharmacists are responsible for
accurate preparation, dispensing and clinical verification of patients’
chemotherapy, targeted therapy and supportive medication orders.
However
both EAHP and ESOP are ambitious to see further development of the
pharmacist’s role in cancer treatment and see unrealised opportunities
at the European and national level for increasing the input of
pharmacist expertise to treatment decisions and the patient experience.
The two organisations have therefore issued a short 5 point summary of
recommendations to national and international health policy makers:
1. Recognise
the need to encourage the role of the pharmacist in multiprofessional
cancer care teams. This helps to ensure flexibility of service, best use
of workforce skills and best outcomes for patients;
2. Promote the concept of having a lead oncology pharmacist in cancer centres to manage and organise pharmaceutical care;
3. Develop
and implement clear Standards in the management and assessment of
chemotherapy treatment and the quality of oncology clinical pharmacy
service provision;
4. Appreciate the specialised
nature of hospital pharmacy, and the hospital pharmacist’s particular
expertise in working with specialised and novel medications; and,
5. Support
high standards in hospital pharmacy service through the development of
accredited and certified hospital pharmacy qualifications, including
oncology
Dr Roberto Frontini, President of the EAHP said: “Every
one of us is affected by cancer and all of us will know someone taken
by this prevalent class of disease. We all therefore have a direct stake
in seeing continuous improvement of cancer care across Europe. Central
to achieving that is advancing the role of the hospital pharmacist in
the treatment pathway. EAHP and ESOP’s 5 point plan provides a framework
that we urge health policy makers to give thought to on World Cancer
Day as they consider how to improve cancer care in their jurisdiction.”
Klaus Meier, President of ESOP said: “Improving
the standard of cancer care in Europe requires close collaboration
across professions, health systems and countries. ESOP and EAHP are
working together to raise educational and service standards in hospital
and oncology pharmacy across all our member countries. However, to
achieve this in full we need the support of health policy planners at
all levels. We hope this 5 point plan can form a basis for securing
greater levels of practical support.”
ENDS
For further information please contact Richard Price, EAHP Policy and Advocacy Officer
Notes to Editors:
1.
The European Association of Hospital Pharmacists (EAHP) is a working
community of national associations of hospital pharmacists. Its
membership includes representatives of national hospital pharmacy
associations in almost all the European Union (EU) member states, in
addition to Switzerland, Norway, Serbia, Turkey, Croatia, the Former
Yugoslav Republic Of Macedonia (FYROM) and Bosnia Herzegovina .
Membership is increasing each year and, at present, EAHP represents the
interest of over 21,000 hospital pharmacists in 31 countries all over
Europe.
www.eahp.eu
2.
The European Society of Oncology Pharmacy (ESOP) is constituted of 31
member countries and has 2,600 members. The Society’s primary aim is to
support the optimal treatment for cancer patients. It does this by
developing and promoting clinical and oncology pharmacy practice and
making information on knowledge and achievements in cancer treatment and
activities available to the public. In this area it has, for example,
developed the quality standard of oncology service pharmacy (QuapoS).
www.esop.eu
3.
World Cancer Day is marked on February 4 to raise awareness of cancer
and to encourage its prevention, detection, and treatment. It is led by
the Union for International Cancer Control, a global consortium of more
than 470 cancer-fighting organisations in over 120 countries.
www.worldcancerday.org
4. The 17th Annual Congress of the European Association of Hospital Pharmacists will be held in Milan 21-23 March.
More information here
http://www.eahp.eu/Congresses/2012-Congress-Milan-Italy
5.
The first scientific conference of ESOP, together with the European
CanCer Organisation (ECCO), the European Conference of Oncology Pharmacy
(ECOP), will be held in Budapest September 27th to 29th 2012.
More information here:
http://www.ecco-org.eu/Conferences/Conferences/ECOP-2012/~/media/ECCO%20documents/ECCO%20sections/Congresses%20and%20Conferences/ECOP%202012/LR_110155_ECOP2012_progr_overview_V02.ashx